Human immunodeficiency virus type 1 Vpr: Oligomerization is an essential feature for its incorporation into virus particles

Virology Journal

Volumn 7, Issue , 2010, Pages

  Venkatachari, Narasimhan J ^a   Walker, Leah A ^a   Tastan, Oznur ^b   Le, Thien ^a   Dempsey, Timothy M ^a   Li, Yaming ^a   Yanamala, Naveena ^c   Srinivasan, Alagarsamy ^d   Klein Seetharaman, Judith ^b,c   Montelaro, Ronald C ^e   Ayyavoo, Velpandi ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Carnegie Mellon University   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NanoBio Diagnostics   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; OLIGOMER; VPR PROTEIN;

ARTICLE; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; CELL NUCLEUS; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; OLIGOMERIZATION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; CONFORMATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; CELL LINE; HIV-1; HUMANS; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; VIRION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77953055741     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-119     Document Type: Article

References (53)

1. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. EA Cohen G Dehni JG Sodroski WA Haseltine, J Virol 1990 64 3097 3099 2139896
2. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. RI Connor BK Chen S Choe NR Landau, Virology 1995 206 935 944 10.1006/viro.1995.1016 7531918
3. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. EO Freed G Englund MA Martin, J Virol 1995 69 3949 3954 7745752
4. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. RA Subbramanian A Kessous-Elbaz R Lodge J Forget XJ Yao D Bergeron EA Cohen, J Exp Med 1998 187 1103 1111 10.1084/jem.187.7.1103 9529326
5. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. JJ Lum OJ Cohen Z Nie JG Weaver TS Gomez XJ Yao D Lynch AA Pilon N Hawley JE Kim, et al. J Clin Invest 2003 111 1547 1554 12750404
6. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. B Wang YC Ge P Palasanthiran SH Xiang J Ziegler DE Dwyer C Randle D Dowton A Cunningham NK Saksena, Virology 1996 223 224 232 10.1006/viro.1996.0471 8806556
7. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission. VR Yedavalli N Ahmad, AIDS Res Hum Retroviruses 2001 17 911 923 10.1089/088922201750290032 11461677
8. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. VR Yedavalli C Chappey N Ahmad, J Virol 1998 72 6937 6943 9658150 (Pubitemid 28324021)
9. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. NL Michael G Chang LA d'Arcy PK Ehrenberg R Mariani MP Busch DL Birx DH Schwartz, J Virol 1995 69 4228 4236 7769682
10. Coinfection and genetic recombination between HIV-1 strains: possible biological implications in Australia and South East Asia. NK Saksena B Wang YC Ge SH Xiang DE Dwyer AL Cunningham, Ann Acad Med Singapore 1997 26 121 127 9140590
11. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. WC Goh ME Rogel CM Kinsey SF Michael PN Fultz MA Nowak BH Hahn M Emerman, Nat Med 1998 4 65 71 10.1038/nm0198-065 9427608
12. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging. JV Fritz P Didier JP Clamme E Schaub D Muriaux C Cabanne N Morellet S Bouaziz JL Darlix Y Mely H de Rocquigny, Retrovirology 2008 5 87 10.1186/1742-4690-5-87 18808682
13. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. LJ Zhao L Wang S Mukherjee O Narayan, J Biol Chem 1994 269 32131 32137 7798208
14. Protein oligomerization: how and why. MH Ali B Imperiali, Bioorg Med Chem 2005 13 5013 5020 10.1016/j.bmc.2005.05.037 15993087
15. Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag). Y Jenkins O Pornillos RL Rich DG Myszka WI Sundquist MH Malim, J Virol 2001 75 10537 10542 10.1128/JVI.75.21.10537-10542. 2001 11581428 (Pubitemid 32948090)
16. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. B Poon IS Chen, J Virol 2003 77 3962 3972 10.1128/JVI.77.7.3962-3972.2003 12634356
17. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. PK Tungaturthi BE Sawaya SP Singh B Tomkowicz V Ayyavoo K Khalili RG Collman S Amini A Srinivasan, Biomed Pharmacother 2003 57 20 24 10.1016/S0753-3322(02)00328-1 12642033
18. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). B Majumder NJ Venkatachari A Srinivasan V Ayyavoo, Curr HIV Res 2009 7 169 177 10.2174/157016209787581445 19275586
19. The role of Vpr in HIV-1 pathogenesis. JL Andersen V Planelles, Curr HIV Res 2005 3 43 51 10.2174/1570162052772988 15638722
20. NMR structure of the HIV-1 regulatory protein VPR. N Morellet S Bouaziz P Petitjean BP Roques, J Mol Biol 2003 327 215 227 10.1016/S0022-2836(03)00060-3 12614620
21. NMR structure of the HIV-1 regulatory protein Vpr in H2O/ trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. K Wecker N Morellet S Bouaziz BP Roques, Eur J Biochem 2002 269 3779 3788 10.1046/j.1432-1033.2002.03067.x 12153575
22. Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr. SP Singh B Tomkowicz D Lai M Cartas S Mahalingam VS Kalyanaraman R Murali A Srinivasan, J Virol 2000 74 10650 10657 10.1128/JVI.74.22.10650-10657.2000 11044109
23. Nuclear import, virion incorporation, and cell cycle arrest/ differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. S Mahalingam V Ayyavoo M Patel T Kieber-Emmons DB Weiner, J Virol 1997 71 6339 6347 9261351
24. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. S Mahalingam M Patel RG Collman A Srinivasan, Virology 1995 214 647 652 10.1006/viro.1995.0079 8553570
25. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. S Mahalingam RG Collman M Patel CE Monken A Srinivasan, Virology 1995 212 331 339 10.1006/viro.1995.1490 7571402
26. Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo. J Votteler N Studtrucker S Sorgel J Munch E Rucker F Kirchhoff B Schick P Henklein T Fossen K Bruns, et al. J Virol 2007 81 9572 9576 10.1128/JVI.02803-06 17553868
27. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. S Bourbigot H Beltz J Denis N Morellet BP Roques Y Mely S Bouaziz, Biochem J 2005 387 333 341 10.1042/BJ20041759 15571493
28. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication. D Thotala EA Schafer PK Tungaturthi B Majumder ML Janket M Wagner A Srinivasan S Watkins V Ayyavoo, Virology 2004 328 89 100 10.1016/j.virol.2004. 07.013 15380361
29. ClusPro: a fully automated algorithm for protein-protein docking. SR Comeau DW Gatchell S Vajda CJ Camacho, Nucleic Acids Res 2004 32 96 99 10.1093/nar/gkh354 15215358
30. Performance of the first protein docking server ClusPro in CAPRI rounds 3-5. SR Comeau S Vajda CJ Camacho, Proteins 2005 60 239 244 10.1002/prot.20564 15981265
31. The RosettaDock server for local protein-protein docking. S Lyskov JJ Gray, Nucleic Acids Res 2008 36 233 238 10.1093/nar/gkn216 18442991
32. Protein docking using continuum electrostatics and geometric fit. JG Mandell VA Roberts ME Pique V Kotlovyi JC Mitchell E Nelson I Tsigelny LF Ten Eyck, Protein Eng 2001 14 105 113 10.1093/protein/14.2.105 11297668
33. Surveying molecular interactions with DOT. LF Ten Eyck J Mandell VA Roberts M.E Pique, Proceedings of the 1995 ACM/IEEE Supercomputing Conference ACM Press, New York, Hayes A, Simmons M, 1995
34. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J Jin T Sturgeon C Chen SC Watkins OA Weisz RC Montelaro, J Virol 2007 81 11226 11235 10.1128/JVI.00431-07 17686839
35. Predicting oligomeric assemblies: N-mers a primer. SR Comeau CJ Camacho, J Struct Biol 2005 150 233 244 10.1016/j.jsb.2005.03.006 15890272
36. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells. DL Bolton MJ Lenardo, J Virol 2007 81 8878 8890 10.1128/JVI.00122-07 17553871
37. Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag). MA Accola A Ohagen HG Gottlinger, J Virol 2000 74 6198 6202 10.1128/JVI.74.13.6198-6202.2000 10846106
38. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection. SP Singh P Tungaturthi M Cartas B Tomkowicz TA Rizvi SA Khan VS Kalyanaraman A Srinivasan, Virology 2001 283 78 83 10.1006/viro.2001.0849 11312664
39. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. F Bachand XJ Yao M Hrimech N Rougeau EA Cohen, J Biol Chem 1999 274 9083 9091 10.1074/jbc.274.13.9083 10085158
40. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. W Paxton RI Connor NR Landau, J Virol 1993 67 7229 7237 8230445
41. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. MH Malim M Emerman, Cell Host Microbe 2008 3 388 398 10.1016/j.chom.2008.04.008 18541215
42. The Vpr protein from HIV-1: distinct roles along the viral life cycle. E Le Rouzic S Benichou, Retrovirology 2005 2 11 10.1186/1742-4690-2-11 15725353
43. Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients. D Mologni P Citterio B Menzaghi B Zanone Poma C Riva V Broggini A Sinicco L Milazzo F Adorni S Rusconi, et al. Aids 2006 20 567 574 10.1097/01.aids.0000210611.60459. 0e 16470121
44. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. SM Lang M Weeger C Stahl-Hennig C Coulibaly G Hunsmann J Muller H Muller-Hermelink D Fuchs H Wachter MM Daniel, et al. J Virol 1993 67 902 912 8380472 (Pubitemid 23032069)
45. The role of Vpr in the regulation of HIV-1 gene expression. J Cui PK Tungaturthi V Ayyavoo M Ghafouri H Ariga K Khalili A Srinivasan S Amini BE Sawaya, Cell Cycle 2006 5 2626 2638 17172832
46. Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion. H Zhu H Jian LJ Zhao, Retrovirology 2004 1 26 10.1186/1742-4690-1-26 15363109
47. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. B Muller U Tessmer U Schubert HG Krausslich, J Virol 2000 74 9727 9731 10.1128/JVI.74.20.9727-9731.2000 11000245
48. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. XJ Yao RA Subbramanian N Rougeau F Boisvert D Bergeron EA Cohen, J Virol 1995 69 7032 7044 7474123
49. HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag. JV Fritz D Dujardin J Godet P Didier J De Mey JL Darlix Y Mely H de Rocquigny, J Virol 84 1585 1596 10.1128/JVI.01691-09 19923179
50. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. Y Nitahara-Kasahara M Kamata T Yamamoto X Zhang Y Miyamoto K Muneta S Iijima Y Yoneda Y Tsunetsugu-Yokota Y Aida, J Virol 2007 81 5284 5293 10.1128/JVI.01928-06 17344301
51. Slipping through the door: HIV entry into the nucleus. MP Sherman WC Greene, Microbes Infect 2002 4 67 73 10.1016/S1286-4579(01)01511-8 11825777
52. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. B Poon K Grovit-Ferbas SA Stewart IS Chen, Science 1998 281 266 269 10.1126/science.281.5374.266 9657723
53. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. H Arokium M Kamata I Chen, J Virol 2009 83 11283 11297 10.1128/JVI.00756-09 19692467